SOLUTIONS & PRODUCTS

From transcatheter and surgical valve therapies to structural interventions,

we’ve built a broad structural heart portfolio across the spectrum to restore health and improve quality of life for patients with structural heart disease.

YOUR PARTNER OF CHOICE
FOR STRUCTURAL HEART SOLUTIONS

Abbott offers a broad portfolio of structural heart solutions for an array of conditions. We invest in creating innovative technologies and advancing science, with the ultimate goal of helping patients achieve better health and improved quality of life. With our legacy of innovation, product diversity, safety, and performance, Abbott is your partner for structural heart therapies.

Some of the ways Abbott demonstrates its leadership in the industry include:

  • Established leader in transcatheter edge-to-edge repair (TEER)* with MitraClipTM1
  • Offering among the broadest occluder portfolios, with 20+ years of leadership1
  • Demonstrating exceptional hemodynamics with tissue valves, and an impressive 40-year legacy with mechanical valves
  • Providing outstanding & competitive clinical outcomes physicians expect from the latest generation TAVI system


*TEER is also referred to as TMVr (transcatheter mitral valve repair)

150K+

patients treated
 

Established leader in
transcatheter mitral valve repair
with MitraClipTM 1

20+

years of leadership
in occluders

We offer a broad portfolio
with PFO, LAA, PDA, septal,
and muscular VSD occluders

40

year legacy
 

We have an impressive 40-year legacy with mechanical valves and have demonstrated exceptional hemodynamics with tissue valves

TRANSCATHETER VALVE SOLUTIONS

BUILT TO HELP
PATIENTS RECLAIM
THEIR LIVES

Our minimally invasive transcatheter mitral valve repair therapy delivers excellent outcomes, and are particularly valuable for select patients who are not eligible for surgical valve repair.

EXPLORE TRANSCATHETER VALVE SOLUTIONS

SURGICAL VALVE SOLUTIONS

DESIGNED TO REBUILD HEALTHIER HEARTS

Our comprehensive surgical valve portfolio delivers long-term durability and performance, exceptional hemodynamics, and streamlined implantability.

Explore SURGICAL VALVE SOLUTIONS

STRUCTURAL INTERVENTIONS

BUILT FOR THE AGES.
DESIGNED FOR
COMPLETE CLOSURE.

Our occluders are built to close an opening in patients’ hearts—saving and restoring lives by providing closure with confidence.

Explore structural interventionS

Explore the interactive heart model below to learn more about our products and solutions across the structural heart spectrum.

Mitral Regurgitation

A condition in which the mitral valve does not close completely during the contraction of the left ventricle, causing blood to leak backward into the left atrium.
Click on a product name to learn more about our therapy solutions
  • MitraClipTM Therapy

    MitraClipTM Therapy is a minimally invasive TMVr therapy that delivers a treatment option for select patients with mitral regurgitation who would otherwise go untreated.*
    *TMVr is also referred to as TEER (Transcatheter edge-to-edge repair)
    MitraClip Therapy for mitral regurgitation
    Learn More
  • EpicTM Plus Mitral Stented Tissue Valve

    The EpicTM Plus Mitral stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic mitral heart valve.
    Epic Plus Supra stented tissue valve
    Learn More
EpicTM Plus MitralMitraClipTM
×

Aortic Stenosis

A narrowing of the aortic valve, which reduces or blocks blood flow from the left ventricle to the aorta.
Click on a product name to learn more about our therapy solutions
  • PorticoTM Valve

    The PorticoTM with FlexNavTM TAVI system is a minimally invasive treatment for patients with aortic valve stenosis.
    Abbott Portico with FlexNav TAVI system
    Learn More
  • EpicTM Plus Supra Stented Tissue Valve

    The EpicTM Plus Supra stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.
    Epic Plus Supra stented tissue valve
    Learn More
  • RegentTM MHV

    The RegentTM mechanical heart valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic valve.
    Regent MHV
    Learn More
  • TrifectaTM GT Valve

    The TrifectaTM Valve with GlideTM Technology (GT) is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.
    Trifecta GT Valve
    Learn More
PorticoTMEpicTM Plus SupraRegentTMTrifectaTM GT
×

Stroke Risk Reduction

Left atrial appendage (LAA) closure reduces the risk of stroke in non-valvular AF patient. Percutaneous closure of the patent foramen ovale (PFO) to prevent thrombus formation.
Click on a product name to learn more about our therapy solutions
  • AmplatzerTM AmuletTM LAA Occluder

    A percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in suitable patients with nonvalvular atrial fibrillation.
    Amplatzer Amulet occluder for atrial fibrillation
    Learn More
  • AmplatzerTM TalismanTM PFO Occluder

    Designed for patent foramen ovale (PFO) closure, the AmplatzerTM TalismanTM PFO occluder reduces the risk of recurrent ischemic stroke.
    Amplatzer Talisman PFO occluder
    Learn More
AmplatzerTM AmuletTM LAA OccluderAmplatzerTM TalismanTM PFO Occluder
×

Congenital defects

Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.
Click on a product name to learn more about our therapy solutions
  • AmplatzerTM Septal Occluder

    A percutaneous transcatheter device for patients requiring atrial septal defect (ASD) closure.
    Amplatzer Septal occluder
    Learn More
  • AmplatzerTM VSD Occluder

    Ventricular septal defects (VSDs) are the most common congenital heart defect, and AmplatzerTM Muscular VSD Occluders provide minimally invasive treatment options.
    Amplatzer VSD occluder
    Learn More
AmplatzerTM Septal OccluderAmplatzerTM VSD Occluder
×
MAT-2115844 v2.0 | Item approved for U.S. use only.

MAT-2004253 v7.0 | Item approved for U.S. use only.

Copyright © 2022 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2004021 v13.0  |   Item approved for U.S. use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.